Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
100 Cards in this Set
- Front
- Back
MCV in normocytic anemia
|
80-100
|
|
Possible underlying mechanisms for normocytic anemia (3)
|
inflammation, hemolysis, acute blood loss
|
|
If the rate of change of the hematocrit/hemoglobin is slow in normocytic anemia, think what?
|
Anemia of Chronic Disease (ACD)
|
|
If the rate of change of the hematocrit/hemoglobin is fast in normocytic anemia, think what?
|
hemolysis
|
|
Possible signs of hemolysis (5)
|
jaundice, icterus, HSM, increased reticulocytes, decreased haptoglobin
|
|
If there is evidence of hemolysis in normocytic anemia, what should you look for on blood smear?
|
shistocytes or spherocytes
|
|
Differential Diagnosis for Normocytic anemia (5)
|
ACD, acute blood loss, multifactorial anemia, renal failure associated anemia, aplastic anemia, or hemolysis
|
|
Two types of hemolytic anemia
|
intrinsic and extrinsic
|
|
Another name for anemia of chronic disease
|
anemia of inflammation
|
|
2nd most common type of anemia
|
Anemia of Chronic Disease (ACD)
|
|
Anemia of Chronic Disease usually presents as normocytic, but may also present as?
|
microcytic
|
|
What is the key pathology behind anemia of chronic disease?
|
disturbance in iron homeostatis as a result of chronic inflammation which leads to increased uptake and retention of iron within macrophages as ferritin
|
|
The net result of the two combined inflammatory processes involved in ACD is what?
|
decreased iron availability in the bone marrow which leads to less RBC being produced as well as reduced RBC survival
|
|
What is the broad definition of Multiple Medical Problems (MMP)?
|
presence of several systemic conditions (including non inflammatory conditions) that mat also be a clinical attributable cause of ACD
|
|
Symptoms in ACD
|
typical anemia symptoms that are usually mild
|
|
Treatment of ACD
|
treat the underlying inflammatory process; iron replacement only if severe, but generally not recommended if there isn't an iron deficiency; blood transfusion PRN; EPO consideration
|
|
In what patients with ACD is EPO considered in (as treatment)?
|
cancer pts. w/ chemo tx, chronic kidney dz, HIV and myelosuppressive S.E. of therapy
|
|
ACD often coexists with what other type of anemia?
|
Iron def. Anemia
|
|
Typical presentation of acute blood loss
|
usually source of bleeding is evident, but may be masked in hospitalized pt. w/ unusual source
|
|
Why is the CBC only somewhat accurate in a patient with acute blood loss who is being actively resuscitated?
|
Because IV fluids and blood products are being added to restore lost blood volume, changing the values on the CBC (SN: If the CBC is done before resuscitation begins, it will show a more accurate picture of pre injury)
|
|
Explain multifactorial anemia.
|
Anemia with more than one cause, part, chronic normocytic anemias that are not easily explained.
|
|
Why is normocytic anemia present in most patients with prolonged renal failure?
|
Slow reduction in erythropoietin production with the end result being less production of RBCs in bone marrow
|
|
What is the treatment for patients with renal failure associated anemia?
|
routine use of synthetic erythropoietin agents (ESAs) to reach a goal of Hg/Hct of 11 and 33%
|
|
Why is routine measurement of serum erythropoietin not extremely diagnostic for renal associated anemia?
|
Because the EPO level will not fall until the Hg is below 10 and even below 10, the EPO level will still fluctuate
|
|
Aplastic anemia, Myelodysplasia, Acute leukemia, Myelofibrosis, magaloblastic anemia, and infiltrative dzs (lymphoma, myeloma) are examples of what broad group of D/O that cause pancytopenia?
|
bone marrow disorders
|
|
Give three examples of non-marrow disorders that can cause pancytopenia.
|
hypersplenism, SLE, infection (TB, AIDS, leishmaniasis, brucellosis)
|
|
What is the mechanism of primary aplastic anemia
|
probably immune related, but not proven
|
|
Types of secondary aplastic anemia (2)
|
inherited (Fanconi's) and Acquired (chromo/radiation, drugs, infections, PNH (paroxysmal nocturnal hemoglobinuria)
|
|
What is PNH?
|
paroxysmal nocturnal hemoglobinuria
|
|
What is Fanconi's Anemia?
|
Autosomal recessive trait that mainly affects the bone marrow. It results in decreased production of all types of blood cells.
|
|
MC characteristic physical anomalies in Fanconi's Anemia
|
skin pigment changes, short stature, upper limb abnormalities, hypogonadal and genitalia changes (male mostly)
|
|
Pancytopenia- definition
|
medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets.
|
|
Explain bimodal distribution of aplastic anemia.
|
occurs between ages 15-25 and again after 60 usually
|
|
Presenting symptoms of aplastic anemia.
|
bleeding, anemia, infections, routine CBC
|
|
How is the diagnosis of aplastic anemia made?
|
CBC and hypocellular bone marrow
|
|
Treatment of aplastic anemia in people under 20
|
bone marrow transplant
|
|
Treatment of aplastic anemia in patient over 45
|
usually immunosuppression
|
|
Why is immunosuppression usually used to treat aplastic anemia in patient over 45?
|
due to increased risks with graft-versus-host disease
|
|
Prognosis for patient under 50 with aplastic anemia
|
70% 5 yr survival
|
|
Prognosis for patient over 70 with aplastic anemia
|
50% 5 yr survival
|
|
What is the one year untreated mortality rate for patients with severe aplastic anemia?
|
70% mortality rate within 1 year
|
|
What is the etiology of PNH?
|
acquired hemolytic anemia caused by a hematopoietic stem cell precursor mutation defect in PIGA gene that cause RBCs to lyse via complement system
|
|
Is PNH considered intrinsic or extrinsic hemolytic anemia?
|
intrinsic
|
|
Patients with PNH are deficient in what two factors?
|
CD55 and C59 which regulate complement response
|
|
When does PNH progress from episodic hemolysis to aplastic anemia?
|
When stem cell injury occurs beyond just the PIGA mutation
|
|
Clinical Signs of PNH
|
cola colored urine, hemosiderin always present in urine sediment, hemosiderin deposits in kidneys on CT/MRI
|
|
Hallmarks of intravascular hemolysis
|
elevated retic count and elevated serum LDH w/ low serum haptoglobin (w/o HSM)
|
|
Veins where thrombosis may occur in PNH (considered "unusual locations")
|
hepatic, abdominal, cerebral, or sub dermal veins
|
|
Tx of PNH
|
Eculizumab (anti complement agent) lifelong; adjunct therapy- anticoagulation, iron supplement PRN
|
|
What is intrinsic hemolytic anemia?
|
due to defect in RBC itself
|
|
What is extrinsic hemolytic anemia?
|
hemolysis is caused by an external factor itself
|
|
3 categories of intrinsic hemolytic anemias.
|
Membrane defects, oxidative vulnerability, hemoglobinopathies
|
|
4 categories/causes of extrinsic hemolytic anemias.
|
immune, microangiopathic, infection, burns/ hypersplenism
|
|
Is haptoglobin increased or decreased in hemolytic anemias?
|
reduced- because it binds with the free hemoglobin that is released in the serum during hemolysis
|
|
Is indirect bili increased or decreased in hemolytic anemia?
|
increased with significant intravascular hemolysis
|
|
Is LDH increased or decreased in hemolytic anemia?
|
increased- it is released from lysed RBCs
|
|
Is the reticulocyte count and RPI increased or decreased in hemolytic anemia?
|
usually increased (normal or low if coexisting hypoproliferative d/o of bone marrow)
|
|
What is the cause of hereditary spherocytosis?
|
It is a chronic hemolytic anemia caused by RBC membrane defect in spectrin
|
|
How do you distinguish between Autoimmune Hemolytic Anemia and Hereditary Spherocytosis?
|
negative Coombs' test
|
|
The reason why hereditary spherocytosis may go undetected until adulthood?
|
due to variable penetrance
|
|
What test is performed sometimes to diagnose Hereditary Spherocytosis when Coombs is negative and hemolysis is present?
|
Osmotic fragility test
|
|
What does an abnormal Osmotic fragility test indicate?
|
an increased presence of spherocytes (test may be falsely negative in mild HS)
|
|
Is G6PD deficiency an intrinsic or extrinsic defect?
|
intrinsic
|
|
What is oxidative stress?
|
cellular damage that occurs from free radicals that cannot be fully neutralized by antioxidants
|
|
What is the most frequent cause of oxidative stress?
|
medications and infections
|
|
What is G6PD Deficiency?
|
hereditary (X-linked) enzyme deficiency that results in hemolysis with oxidative stress
|
|
What is the importance of G6PD's function in keeping gluthathione in a reduced state?
|
protects hemoglobin from oxidative denaturation
|
|
What population has a higher % of reduced G6PD activity?
|
African Americans
|
|
Why can lab measures of G6PD be falsely normal is measured right after a hemolytic episode?
|
Because G6PD activity declines in older RBCs so older blood cell populations are affected. After hemolysis, it is younger RBC with more G6PD activity left
|
|
What are Heinz Bodies?
|
oxidized hemoglobin that has formed precipitants that can be seen on peripheral smear
|
|
What classes of drugs may induce oxidative stress?
|
antimalarials (primaquine, dapsone), sulfonamides, analgesics
|
|
Best tx for G6PD Def.
|
avoid oxidative stress
|
|
Autosomal recessive d/o caused by a point mutation in the B globin chain gene that causes Hem S to form
|
Sickle Cell Anemia
|
|
Populations most affected by sickle cell
|
Africans (some others in Malaria belt); African Americans
|
|
What are Sickle "Crises"?
|
Sickle Cell anemia has an episodic course- episodes are "crises"
|
|
Lab Findings with Sickle Cell
|
chronic normocytic anemia; chronic reticulocytosis (even higher with crises)
|
|
What is Acute Chest Syndrome?
|
found in Sickle Cell- fevers, chest pain, hypoxemia, and pulm. Infiltrates
|
|
Tx for Sickle Cell anemia
|
supportive care (O2, fluids, analgesia), hydroxyurea (to incr. HgB F), transfusions
|
|
What is Autoimmune Hemolytic Anemia caused by?
|
extrinsic defect caused by acquired antibodies to a component of the RBC membrane
|
|
What determines the severity of AIHA?
|
amount/type of Ab, activity of Ab, Ab ability to fix complement
|
|
Most common AIHA
|
warm
|
|
Antibodies involved in warm AIHA
|
IgG Ab that react to normal body temps
|
|
Usual result in warm AIHA
|
results in extravascular hemolysis (spleen)
|
|
Antibodies involved in Cold AIHA
|
IgM that only reacts at reduced body temperature
|
|
Usual result in cold AIHA
|
intravascular hemolysis (liver)
|
|
Is complement activity increased or decreased in "cold" AIHA?
|
increased
|
|
Etiology of warm AIHA
|
idiopathic (majority); lymphomas, SLE/autoimmune d/o's; drugs, post viral infections
|
|
Etiology of cold AIHA
|
lymphoproliferative dz, infections (mycoplasma, Mono-EBV)
|
|
Most pertinent clinical feature of AIHA
|
episodic course usually ass. w/ physiologic stress
|
|
What is seen on smear of AIHA?
|
significant spherocytes
|
|
Why is warm AIHA usually more severe?
|
more frequent activity
|
|
What does the severity of cold AIHA depend on?
|
the temperature
|
|
Tx of warm AIHA
|
immunosuppression, complicated transfusions, splenectomy
|
|
Tx of cold AIHA
|
avoidance
|
|
Intravascular hemolysis due to RBC fragmentation (trauma) that results in schistocytosis and thrombocytopenia
|
Microangiopathic Hemolytic Anemia (MAHA)
|
|
What is often the role of infectious agents in hemolytic anemia?
|
the infectious agent can act as a facilitator to other hemolytic processes
|
|
How does aplastic anemia present?
|
As pancytopenia
|
|
How are hemolytic anemias recognized?
|
by reliable, rapid hematocrit drop in the absence of bleeding
|
|
List intrinsic hemolytic defects
|
HS, G6PD, sickle cell
|
|
List extrinsic hemolytic defects
|
AIHA warm and cold
|